Pfizer Joins With Bangladesh Bank On Rural Co-op Clinic Project
This article was originally published in PharmAsia News
A bank in Bangladesh and U.S. drug maker Pfizer are joining forces to make affordable health care available as private insurance for poor people on a global basis. Pfizer plans to lend three senior employees to the project for a year and provide $200,000 to help expand a co-operative network of rural clinics developed by Bangladesh's Grameen Bank. The clinics are funded by low-cost, pre-paid premiums and low payback fees. Pfizer sees the project as enhancing its plan to expand business beyond sales into profit-making health care. (Click here for more
You may also be interested in...
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
The UK's Celleron has attracted a "blue chip suite of investors" to an Irish-domiciled spin-off based on the potential of Roche-developed emactuzumab for TGCT, a debilitating orphan disease that causes joint damage and has limited clinical options.
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.